|
|
|
ONLINE FEATURES
Book Reviews
BW Video
Columnists
Interactive Gallery
Newsletters
Past Covers
Philanthropy
Podcasts
Special Reports
BLOGS
The Auto Beat
Byte of the Apple
Europe Insight
Eye on Asia
Getting In
Investing Insights
The New Entrepreneur
NEXT: Innovation Tools & Trends
On Media
Technology at Work
The Tech Beat
Traveler's Check
TECHNOLOGY
Product Reviews
Tech Stats
Hands On
AUTOS
Home Page
Auto Reviews
Car Care & Safety
INNOVATION
& DESIGN Home Page Architecture Brand Equity Auto Design Game Room SMALLBIZ Smart Answers Success Stories Today's Tip FINANCE Investing: Europe Annual Reports Bloomberg BW50 SCOREBOARDS Hot Growth Companies: 2008 Mutual Funds Info Tech 100 B-SCHOOLS Undergrad Programs Rankings & Profiles |
AUGUST 30, 2004
By Gene G. Marcial PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical (PSSI
) in 2000, sales at PSS -- a distributor of medical supplies to doctors' offices and nursing homes -- stood at $160 million. They've since rocketed to $1.35 billion. No wonder giants McKesson (MCK
), a distributor to hospitals and pharmacies, and Cardinal Health (CAH
), a distributor and producer of health-care products, are eyeballing PSS, say some pros: They hope Smith will sell. McKesson's sales are a hefty $70 billion and Cardinal's $56 billion. Smith doesn't deny he has had informal offers, but he wants to build up the stock's worth to more than analysts' 12-month target of 16. "Given the fast growth of PSS, it would not be right to take less than 20," says Smith. Why do McKesson and Cardinal care about PSS? It's the No. 1 distributor to both the elder-care market and the physicians' market. (McKesson is No. 2 in both.) The doctors' business brings in 60% of PSS's sales, and the elder-care market some 40%. Eric Coldwell of securities firm Robert W. Baird puts earnings at 53 cents in fiscal year 2005 ending Mar. 31, vs. 2004's 42 cents. For fiscal 2006, he sees 70 cents. The stock, now at 9.43, "remains one of our top picks," he says. McKesson and Cardinal didn't return calls for comment.
Note: Unless otherwise noted, neither the sources cited in Inside Wall Street nor their firms hold positions in the stocks under discussion. Similarly, they have no investment banking or other financial relationships with them.
See Gene on Fridays at 1:20 p.m. EST on CNNfn's The Money Gang. Get BusinessWeek directly on your desktop with our RSS feeds. ![]() Add BusinessWeek news to your Web site with our headline feed. Click to buy an e-print or reprint of a BusinessWeek or BusinessWeek Online story or video. To subscribe online to BusinessWeek magazine, please click here. Learn more, go to the BusinessWeekOnline home page | |